Hercules Capital Inc Stock News

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 1) Adaptimmune Therapeutics PLC...

G1 Therapeutics, Inc. (Nasdaq: GTHX), a clinical-stage oncology company, today announced that the company has entered into a debt financing agreement with Hercules Capital, Inc. (NYSE: HTGC) for up to

On CNBC's "Mad Money Lightning Round," Jim Cramer said that Hercules Capital Inc (NYSE: HTGC) is like a venture fund, but we don't know what it owns.Cramer is not a buyer of Caleres Inc (NYSE: CAL). H

Hercules Capital has been severely impacted by the current crisis, and its share price has plunged. However, its sector exposures and balance sheet position sug

Q1 2020 Hercules Capital Inc Earnings Call

Above the Trend Line: your industry rumor central is a recurring feature of insideBIGDATA. In this column, we present a variety of short time-critical news items grouped by category such as M&A activi

Q1'20 results show continued strong performance despite the pandemic. Management took proactive steps to boost liquidity to weather the crisis. Shares look pois

MemSQL, the No-Limits Database for operational analytics and cloud-native applications, has signed a debt facility that provides up to $50 million of

There's nothing "artificial" about these AI stocks to buy now. Each represents cutting-edge technology, and offers solid income along the way.

X4 Pharmaceuticals, Inc. (Nasdaq: XFOR), a leader in the discovery and development of novel therapies targeting diseases resulting from dysfunction of